{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T05:08:11Z","timestamp":1784092091157,"version":"3.55.0"},"reference-count":51,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T00:00:00Z","timestamp":1784073600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Prediction models for postoperative recurrence in papillary thyroid carcinoma (PTC) have increased substantially in recent years. However, recurrence outcomes are inconsistently defined across studies, particularly with respect to structural and biochemical recurrence, and the quality and clinical applicability of existing models remain uncertain.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To systematically review and critically appraise multivariable prediction models for structural postoperative recurrence in pathologically confirmed PTC and to evaluate their predictive performance, methodological quality, and risk of bias.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>PubMed, Embase, and the Cochrane Library were searched from inception to February 2026. Studies developing or validating multivariable prediction models for structural recurrence in adult patients with PTC were included. Data extraction was guided by the CHARMS checklist, and risk of bias was assessed using PROBAST. Findings were synthesized narratively, and an exploratory meta-analysis of discrimination performance from validation studies was conducted where appropriate.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Thirteen retrospective studies met the inclusion criteria, all of which were conducted in East Asian populations. Reported discrimination was generally acceptable, with most AUC or C-index values exceeding 0.70. However, all studies were judged to have a high overall risk of bias, primarily due to limitations in the analysis domain, including inadequate handling of overfitting, insufficient sample size justification, limited reporting of missing data, and reliance on internal validation. Only two studies performed external validation. Exploratory pooling of validation AUCs suggested moderate predictive performance but substantial heterogeneity across studies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Current prediction models for structural recurrence in PTC show promise for individualized risk estimation but remain limited by methodological weaknesses, heterogeneous modelling approaches, inadequate assessment of calibration, and scarce external validation. Future studies should adopt standardized recurrence definitions, improve reporting transparency, and prioritize robust external validation before routine clinical implementation can be recommended.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fendo.2026.1831081","type":"journal-article","created":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T04:46:30Z","timestamp":1784090790000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Prediction models for postoperative recurrence in papillary thyroid carcinoma: a systematic review and critical appraisal"],"prefix":"10.3389","volume":"17","author":[{"given":"Yunqi","family":"Yang","sequence":"first","affiliation":[{"name":"Department of Pharmacy, The Affiliated Yantai Yuhuangding Hospital of Qingdao University","place":["Shandong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengcheng","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, The Affiliated Yantai Yuhuangding Hospital of Qingdao University","place":["Shandong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, The Affiliated Yantai Yuhuangding Hospital of Qingdao University","place":["Shandong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruigang","family":"Diao","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, The Affiliated Yantai Yuhuangding Hospital of Qingdao University","place":["Shandong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenyu","family":"Guo","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, The Affiliated Yantai Yuhuangding Hospital of Qingdao University","place":["Shandong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1097\/CM9.0000000000003284","article-title":"Global burden of thyroid cancer in 2022: Incidence and mortality estimates from GLOBOCAN","volume":"137","author":"Lyu","year":"2024","journal-title":"Chin Med J (Engl)"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2023.0709","article-title":"Survival prognostication in patients with differentiated thyroid cancer and distant metastases: A SEER population-based study","volume":"34","author":"Chen","year":"2024","journal-title":"Thyroid\u00ae"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2010.0021","article-title":"Thyroid cancer incidence patterns in the United States by histologic type, 1992\u20132006","volume":"21","author":"Aschebrook-Kilfoy","year":"2011","journal-title":"Thyroid"},{"key":"B4","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s12022-022-09707-3","article-title":"Overview of the 2022 WHO classification of thyroid neoplasms","volume":"33","author":"Baloch","year":"2022","journal-title":"Endocr Pathol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1001\/jama.2024.5725","article-title":"What is thyroid cancer","volume":"332","author":"Voelker","year":"2024","journal-title":"JAMA"},{"key":"B6","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1001\/jama.2023.26348","article-title":"Thyroid cancer: A review","volume":"331","author":"Boucai","year":"2024","journal-title":"JAMA"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/thy.2015.0020","article-title":"2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer","volume":"26","author":"Haugen","year":"2016","journal-title":"Thyroid"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1159\/000510620","article-title":"Long-term outcome of lobectomy for thyroid cancer","volume":"10","author":"Bosset","year":"2021","journal-title":"Eur Thyroid J"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1159\/000528540","article-title":"Clinical study on the risk factors for the recurrence of papillary thyroid carcinoma","volume":"85","author":"Masui","year":"2023","journal-title":"ORL"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3390\/curroncol29070350","article-title":"Health-related quality of life following total thyroidectomy and lobectomy for differentiated thyroid carcinoma: A systematic review","volume":"29","author":"Landry","year":"2022","journal-title":"Curr Oncol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2019.0652","article-title":"Patient report of recurrent and persistent thyroid cancer","volume":"30","author":"Papaleontiou","year":"2020","journal-title":"Thyroid\u00ae"},{"key":"B12","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1177\/10507256251363120","article-title":"2025 American Thyroid Association management guidelines for adult patients with differentiated thyroid cancer","volume":"35","author":"Ringel","year":"2025","journal-title":"Thyroid\u00ae"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2020.0272","article-title":"Real-world performance of the American Thyroid Association risk estimates in predicting 1-year differentiated thyroid cancer outcomes: A prospective multicenter study of 2000 patients","volume":"31","author":"Grani","year":"2021","journal-title":"Thyroid\u00ae"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2022.0055","article-title":"The prospective implementation of the 2015 ATA guidelines and modified ATA recurrence risk stratification system for treatment of differentiated thyroid cancer in a Canadian tertiary care referral setting","volume":"32","author":"Wu","year":"2022","journal-title":"Thyroid\u00ae"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgae465","article-title":"Improving the risk prediction of the 2015 ATA recurrence risk stratification in papillary thyroid cancer","volume":"110","author":"Wang","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"key":"B16","doi-asserted-by":"publisher","first-page":"4948","DOI":"10.1038\/s41598-021-84504-2","article-title":"Machine learning-based prediction model using clinico-pathologic factors for papillary thyroid carcinoma recurrence","volume":"11","author":"Park","year":"2021","journal-title":"Sci Rep"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1186\/s40644-023-00629-9","article-title":"Analysis of preoperative computed tomography radiomics and clinical factors for predicting postsurgical recurrence of papillary thyroid carcinoma","volume":"23","author":"Xu","year":"2023","journal-title":"Cancer Imaging"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgae601","article-title":"Preoperative serum lipids as novel predictors of survival in 3575 patients with papillary thyroid cancer","volume":"110","author":"Yuan","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"key":"B19","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1186\/s12885-024-12546-6","article-title":"Ultrasound-based nomogram to predict the recurrence in papillary thyroid carcinoma using machine learning","volume":"24","author":"Zhou","year":"2024","journal-title":"BMC Cancer"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.47852\/bonviewMEDIN42024441","article-title":"Towards predicting recurrence risk of differentiated thyroid cancer with a hybrid machine learning model","volume":"3","author":"Chattopadhyay","year":"2024","journal-title":"Medinformatics"},{"key":"B21","doi-asserted-by":"publisher","first-page":"3385","DOI":"10.1038\/s41598-025-33396-7","article-title":"A comparative study on advanced predictive modeling of thyroid cancer recurrence using multi algorithmic machine learning frameworks","volume":"16","author":"Thakur","year":"2025","journal-title":"Sci Rep"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1097\/JS9.0000000000004415","article-title":"Deep learning habitat radiomics based on ultrasound for predicting preoperative locally progression and postoperative recurrence risk of thyroid cancer: A multicenter study","author":"Wenwu","year":"2025","journal-title":"Int J Surg"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2025.1552479","article-title":"A machine learning-based model for predicting recurrence in intermediate- and high-risk differentiated thyroid cancer: Insights from a retrospective single-center study of 2388 patients","volume":"16","author":"Li","year":"2025","journal-title":"Front Endocrinol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1530\/EC-22-0457","article-title":"Accuracy of papillary thyroid cancer prognostic nomograms: A systematic review","volume":"12","author":"Luisa Garo","year":"2023","journal-title":"Endocr Connect"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3390\/ijms27083510","article-title":"Thyroid-originating extracellular vesicles harbor thyroid-specific biomarkers with potential relevance for thyroid cancer recurrence detection","volume":"27","author":"Bobar","year":"2026","journal-title":"Int J Mol Sci"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2024.1461372","article-title":"A hybrid machine learning model combining association rule mining and classification algorithms to predict differentiated thyroid cancer recurrence","volume":"11","author":"Firat Atay","year":"2024","journal-title":"Front Med"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.4836","article-title":"A novel prognostic model for papillary thyroid cancer based on epithelial\u2013mesenchymal transition\u2010related genes","volume":"11","author":"Liu","year":"2022","journal-title":"Cancer Med"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijsu.2021.105906","article-title":"The PRISMA 2020 statement: An updated guideline for reporting systematic reviews","volume":"88","author":"Page","year":"2021","journal-title":"Int J Surg"},{"key":"B29","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s12874-023-01849-0","article-title":"CHARMS and PROBAST at your fingertips: A template for data extraction and risk of bias assessment in systematic reviews of predictive models","volume":"23","author":"Fernandez-Felix","year":"2023","journal-title":"BMC Med Res Methodol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-025-04177-z","article-title":"Analysis of prognostic factors and establishment of a recurrence risk prediction model for papillary thyroid carcinoma based on BRAF stratification","volume":"88","author":"Hu","year":"2025","journal-title":"Endocrine"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1002\/hed.24201","article-title":"Postoperative nomogram for predicting disease-specific death and recurrence in papillary thyroid carcinoma","volume":"38","author":"Lang","year":"2016","journal-title":"Head Neck"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.2147\/IJGM.S486189","article-title":"Application of a novel multimodal-based deep learning model for the prediction of papillary thyroid carcinoma recurrence","volume":"17","author":"Lee","year":"2024","journal-title":"Int J Gen Med"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1268282","article-title":"Risk factors and predictive model for recurrence in papillary thyroid carcinoma: A single-center retrospective cohort study based on 955 cases","volume":"14","author":"Li","year":"2023","journal-title":"Front Endocrinol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.5114\/wiitm.2022.116419","article-title":"An ultrasound model for predicting recurrence of papillary thyroid carcinoma after complete endoscopic resection","volume":"17","author":"Lu","year":"2022","journal-title":"Videosurgery Miniinvasive Tech"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-023-04998-3","article-title":"Nomogram to predict the risk of biochemical recurrence and structural recurrence in patients with stage cN1 papillary thyroid carcinoma","volume":"149","author":"Ma","year":"2023","journal-title":"J Cancer Res Clin Oncol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1186\/s12885-025-14594-y","article-title":"Machine learning models for diagnosing lymph node recurrence in postoperative PTC patients: A radiomic analysis","volume":"25","author":"Pang","year":"2025","journal-title":"BMC Cancer"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1177\/19160216251314750","article-title":"Nomogram predicting progression-free survival in locally advanced papillary thyroid cancer with recurrent laryngeal nerve invasion","volume":"54","author":"Song","year":"2025","journal-title":"J Otolaryngol  Head Neck Surg"},{"key":"B38","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1186\/s12885-024-12146-4","article-title":"Development and validation of prediction models for papillary thyroid cancer structural recurrence using machine learning approaches","volume":"24","author":"Wang","year":"2024","journal-title":"BMC Cancer"},{"key":"B39","doi-asserted-by":"publisher","first-page":"775","DOI":"10.3760\/cma.j.cn112152-20190314-00161","article-title":"Establishment of model to predict lateral neck recurrence of central lymph node metastasis in papillary thyroid carcinoma","volume":"43","author":"Xu","year":"2021","journal-title":"Chin J Oncol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1007\/s13277-015-4532-6","article-title":"Predictive factors for recurrence of differentiated thyroid cancer in patients under 21 years of age and a meta-analysis of the current literature","volume":"37","author":"Qu","year":"2016","journal-title":"Tumor Biol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1433553","article-title":"Current status of the prediction for radio-iodine refractory thyroid cancer: A narrative review","volume":"15","author":"Wang","year":"2024","journal-title":"Front Endocrinol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1440722","article-title":"BRAFV600E\/pTERT double mutated papillary thyroid cancers exhibit immune gene suppression","volume":"15","author":"Sigarteu Chindris","year":"2024","journal-title":"Front Endocrinol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000049200","article-title":"Serum-based BRAF V600E detection improves early diagnosis of papillary thyroid carcinoma: A prospective diagnostic accuracy study compared with ultrasound-guided cytology","volume":"105","author":"Li","year":"2026","journal-title":"Med (Baltimore)"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines14050967","article-title":"Molecular determinants of thyroid cancer progression: Thyroid hormone signaling, the BRAF\/MAPK pathway, and emerging miRNA biomarkers","volume":"14","author":"Lasa","year":"2026","journal-title":"Biomedicines"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2025.1552479","article-title":"A machine learning-based model for predicting recurrence in intermediate- and high-risk differentiated thyroid cancer: Insights from a retrospective single-center study of 2388 patients","volume":"16","author":"Li","year":"2025","journal-title":"Front Endocrinol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrad.2025.112308","article-title":"Complementing interpretable machine learning with synergistic analytical strategies for thyroid cancer recurrence prediction","volume":"191","author":"Oka","year":"2025","journal-title":"Eur J Radiol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgaf487","article-title":"Machine learning prediction of recurrence in pediatric thyroid cancer: Malignant endocrine tumors cohort analysis using XGBoost and SHAP","volume":"111","author":"Redlich","year":"2026","journal-title":"J Clin Endocrinol Metab"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrad.2025.112049","article-title":"Interpretable machine learning for thyroid cancer recurrence predicton: Leveraging XGBoost and SHAP analysis","volume":"186","author":"Schindele","year":"2025","journal-title":"Eur J Radiol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2023.0141","article-title":"The 2023 Bethesda system for reporting thyroid cytopathology","volume":"33","author":"Ali","year":"2023","journal-title":"Thyroid"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1590\/1806-9282.20231511","article-title":"Evangely, the subcategorization has been announced in the 2023 Bethesda system for reporting thyroid cytopathology: Let bygones be bygones in thyroidology","volume":"70","author":"Sengul","year":"2024","journal-title":"Rev Assoc M\u00e9d Bras"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1590\/1806-9282.20210763","article-title":"Blurred lines for management of thyroid nodules in the era of atypia of undetermined significance\/ follicular lesion of undetermined significance: novel subdivisions of categories IIIA and IIIB in a possible forthcoming The Bethesda System for Reporting Thyroid Cytopathology, 3rd edition; amending versus unnecessary","volume":"67","author":"Sengul","year":"2021","journal-title":"Rev Assoc M\u00e9d Bras"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1831081\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T04:46:37Z","timestamp":1784090797000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1831081\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,15]]},"references-count":51,"alternative-id":["10.3389\/fendo.2026.1831081"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2026.1831081","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,15]]},"article-number":"1831081"}}